Drugs / 4CMenB vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05766904 | May 2023 → Sep 2026 overdue | gonorrhea | Chinese University of Hong Kong | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 4CMenB vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05766904 ↗ |
| Modality | Vaccine | “Four-component MenB vaccine” NCT05766904 ↗ |
| Route | Intramuscular | “Intramuscular injection of 2 doses of 0.5mL 4CMenB vaccine 1 month apart” NCT05766904 ↗ |